Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$119.79 USD
+1.35 (1.14%)
Updated Oct 31, 2025 03:59 PM ET
After-Market: $119.74 -0.05 (-0.04%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Fundamental Charts
About Dividend Yield (TTM)
For Gilead Sciences, Inc., the company has a dividend yield of 2.67% compared to the Medical - Biomedical and Genetics industry's median yield of zero percent.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
GILD 119.79 +1.35(1.14%)
Will GILD be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for GILD based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for GILD
GILD Q3 Earnings and Sales Beat Estimates, HIV and Livdelzi Sales Grow
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
GILD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Gilead (GILD) Reports Q3 Earnings: What Key Metrics Have to Say
Gilead Sciences (GILD) Q3 Earnings and Revenues Top Estimates
Should You Buy, Hold, or Sell GILD Stock Ahead of Q3 Earnings?
Other News for GILD
Gilead price target raised to $145 from $127 at Truist
Gilead price target raised by $18 at Truist, here's why
Is GILD likely to continue higher? Crossed Above 20 Day Moving Average shows up after advancing 1.14%
Gilead's HIV Drugs Power Earnings Beat, Company Eyes Multiple Launches By 2026
Nasdaq 100 Rebounds, Amazon Jumps 10% On Strong Earnings: What's Moving Markets Friday?